nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.185	0.291	CbGbCtD
Bezafibrate—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.159	0.25	CbGbCtD
Bezafibrate—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.107	0.168	CbGbCtD
Bezafibrate—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0465	0.0732	CbGbCtD
Bezafibrate—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0449	0.0706	CbGbCtD
Bezafibrate—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0433	0.0681	CbGbCtD
Bezafibrate—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0199	0.0313	CbGbCtD
Bezafibrate—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0182	0.0286	CbGbCtD
Bezafibrate—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0124	0.0195	CbGbCtD
Bezafibrate—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00632	0.727	CbGdCrCtD
Bezafibrate—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00237	0.272	CbGdCrCtD
Bezafibrate—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00166	0.0448	CbGpPWpGaD
Bezafibrate—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00141	0.038	CbGpPWpGaD
Bezafibrate—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00121	0.0327	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—NF2—peripheral nervous system neoplasm	0.0012	0.0326	CbGpPWpGaD
Bezafibrate—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00115	0.031	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—SMARCB1—peripheral nervous system neoplasm	0.000967	0.0262	CbGpPWpGaD
Bezafibrate—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000954	0.0258	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000934	0.0252	CbGpPWpGaD
Bezafibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000923	0.0249	CbGpPWpGaD
Bezafibrate—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000907	0.0245	CbGpPWpGaD
Bezafibrate—PPARA—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000903	0.0244	CbGpPWpGaD
Bezafibrate—PPARD—The citric acid (TCA) cycle and respiratory electron transport—COX2—peripheral nervous system neoplasm	0.000899	0.0243	CbGpPWpGaD
Bezafibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000873	0.0236	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000791	0.00249	CcSEcCtD
Bezafibrate—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000791	0.00249	CcSEcCtD
Bezafibrate—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000781	0.00245	CcSEcCtD
Bezafibrate—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000762	0.00239	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—peripheral nervous system neoplasm	0.000751	0.00236	CcSEcCtD
Bezafibrate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.00236	CcSEcCtD
Bezafibrate—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000748	0.00235	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000743	0.00234	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000742	0.00233	CcSEcCtD
Bezafibrate—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000739	0.00232	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000739	0.00232	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000736	0.00231	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000736	0.00231	CcSEcCtD
Bezafibrate—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000735	0.00231	CcSEcCtD
Bezafibrate—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000734	0.00231	CcSEcCtD
Bezafibrate—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000731	0.0023	CcSEcCtD
Bezafibrate—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000731	0.0023	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000727	0.00228	CcSEcCtD
Bezafibrate—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000725	0.00228	CcSEcCtD
Bezafibrate—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00072	0.00226	CcSEcCtD
Bezafibrate—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000717	0.00225	CcSEcCtD
Bezafibrate—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000711	0.00224	CcSEcCtD
Bezafibrate—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000711	0.00224	CcSEcCtD
Bezafibrate—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000702	0.00221	CcSEcCtD
Bezafibrate—Constipation—Topotecan—peripheral nervous system neoplasm	0.000697	0.00219	CcSEcCtD
Bezafibrate—Pain—Topotecan—peripheral nervous system neoplasm	0.000697	0.00219	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—peripheral nervous system neoplasm	0.000695	0.00218	CcSEcCtD
Bezafibrate—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000694	0.00218	CcSEcCtD
Bezafibrate—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000691	0.00217	CcSEcCtD
Bezafibrate—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000691	0.00217	CcSEcCtD
Bezafibrate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000691	0.00217	CcSEcCtD
Bezafibrate—Pain—Tretinoin—peripheral nervous system neoplasm	0.000691	0.00217	CcSEcCtD
Bezafibrate—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000689	0.00217	CcSEcCtD
Bezafibrate—Pain—Melphalan—peripheral nervous system neoplasm	0.000682	0.00214	CcSEcCtD
Bezafibrate—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000668	0.0021	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000666	0.00209	CcSEcCtD
Bezafibrate—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000665	0.00209	CcSEcCtD
Bezafibrate—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000661	0.0179	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000661	0.00208	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000661	0.00208	CcSEcCtD
Bezafibrate—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00066	0.00207	CcSEcCtD
Bezafibrate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000656	0.00206	CcSEcCtD
Bezafibrate—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000649	0.00204	CcSEcCtD
Bezafibrate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000647	0.00203	CcSEcCtD
Bezafibrate—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000647	0.00203	CcSEcCtD
Bezafibrate—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000644	0.00202	CcSEcCtD
Bezafibrate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000642	0.00202	CcSEcCtD
Bezafibrate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000642	0.00202	CcSEcCtD
Bezafibrate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000639	0.00201	CcSEcCtD
Bezafibrate—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000639	0.00201	CcSEcCtD
Bezafibrate—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000639	0.00201	CcSEcCtD
Bezafibrate—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000639	0.00201	CcSEcCtD
Bezafibrate—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000636	0.002	CcSEcCtD
Bezafibrate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000634	0.00199	CcSEcCtD
Bezafibrate—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00063	0.00198	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000627	0.00197	CcSEcCtD
Bezafibrate—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000625	0.0169	CbGpPWpGaD
Bezafibrate—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.000621	0.00195	CcSEcCtD
Bezafibrate—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000616	0.00194	CcSEcCtD
Bezafibrate—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000615	0.00193	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.00061	0.00192	CcSEcCtD
Bezafibrate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000608	0.00191	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000607	0.00191	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000602	0.00189	CcSEcCtD
Bezafibrate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0006	0.00189	CcSEcCtD
Bezafibrate—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.0006	0.00188	CcSEcCtD
Bezafibrate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000595	0.00187	CcSEcCtD
Bezafibrate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000595	0.00187	CcSEcCtD
Bezafibrate—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000595	0.00187	CcSEcCtD
Bezafibrate—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000591	0.00186	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000591	0.00186	CcSEcCtD
Bezafibrate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000588	0.00185	CcSEcCtD
Bezafibrate—Infection—Vincristine—peripheral nervous system neoplasm	0.000586	0.00184	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.00182	CcSEcCtD
Bezafibrate—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000578	0.00182	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000577	0.0156	CbGpPWpGaD
Bezafibrate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000576	0.00181	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000575	0.00181	CcSEcCtD
Bezafibrate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000572	0.0018	CcSEcCtD
Bezafibrate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000572	0.0018	CcSEcCtD
Bezafibrate—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000566	0.00178	CcSEcCtD
Bezafibrate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000565	0.00178	CcSEcCtD
Bezafibrate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000564	0.00177	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.00177	CcSEcCtD
Bezafibrate—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000563	0.00177	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.00176	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.00175	CcSEcCtD
Bezafibrate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000557	0.00175	CcSEcCtD
Bezafibrate—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.00174	CcSEcCtD
Bezafibrate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000553	0.00174	CcSEcCtD
Bezafibrate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000553	0.00174	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.00172	CcSEcCtD
Bezafibrate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000546	0.00172	CcSEcCtD
Bezafibrate—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000544	0.00171	CcSEcCtD
Bezafibrate—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000541	0.0017	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00054	0.0017	CcSEcCtD
Bezafibrate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000539	0.00169	CcSEcCtD
Bezafibrate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000539	0.00169	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000538	0.00169	CcSEcCtD
Bezafibrate—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000537	0.00169	CcSEcCtD
Bezafibrate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000534	0.00168	CcSEcCtD
Bezafibrate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000534	0.00168	CcSEcCtD
Bezafibrate—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000534	0.00168	CcSEcCtD
Bezafibrate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00165	CcSEcCtD
Bezafibrate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00165	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.00165	CcSEcCtD
Bezafibrate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000522	0.00164	CcSEcCtD
Bezafibrate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000518	0.00163	CcSEcCtD
Bezafibrate—Rash—Topotecan—peripheral nervous system neoplasm	0.000514	0.00161	CcSEcCtD
Bezafibrate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000513	0.00161	CcSEcCtD
Bezafibrate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000511	0.0138	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000511	0.00161	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000511	0.00161	CcSEcCtD
Bezafibrate—Headache—Topotecan—peripheral nervous system neoplasm	0.00051	0.0016	CcSEcCtD
Bezafibrate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00051	0.0016	CcSEcCtD
Bezafibrate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00051	0.0016	CcSEcCtD
Bezafibrate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000509	0.0016	CcSEcCtD
Bezafibrate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000509	0.0016	CcSEcCtD
Bezafibrate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000506	0.00159	CcSEcCtD
Bezafibrate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000506	0.00159	CcSEcCtD
Bezafibrate—Pain—Vincristine—peripheral nervous system neoplasm	0.000505	0.00159	CcSEcCtD
Bezafibrate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000505	0.00159	CcSEcCtD
Bezafibrate—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000503	0.00158	CcSEcCtD
Bezafibrate—Rash—Melphalan—peripheral nervous system neoplasm	0.000503	0.00158	CcSEcCtD
Bezafibrate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000502	0.00158	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.00157	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.00156	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000491	0.00154	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000491	0.00154	CcSEcCtD
Bezafibrate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000487	0.00153	CcSEcCtD
Bezafibrate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000487	0.00153	CcSEcCtD
Bezafibrate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.00152	CcSEcCtD
Bezafibrate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000484	0.00152	CcSEcCtD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000483	0.0131	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000483	0.00152	CcSEcCtD
Bezafibrate—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000483	0.00152	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000481	0.00151	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000481	0.00151	CcSEcCtD
Bezafibrate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00048	0.00151	CcSEcCtD
Bezafibrate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00048	0.00151	CcSEcCtD
Bezafibrate—PPARD—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000478	0.0129	CbGpPWpGaD
Bezafibrate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000475	0.00149	CcSEcCtD
Bezafibrate—Infection—Etoposide—peripheral nervous system neoplasm	0.000475	0.00149	CcSEcCtD
Bezafibrate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000474	0.00149	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.00149	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000471	0.00148	CcSEcCtD
Bezafibrate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000468	0.00147	CcSEcCtD
Bezafibrate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000467	0.00147	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.00146	CcSEcCtD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000456	0.0123	CbGpPWpGaD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.00143	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.00143	CcSEcCtD
Bezafibrate—PPARA—PPAR Alpha Pathway—MYC—peripheral nervous system neoplasm	0.000454	0.0123	CbGpPWpGaD
Bezafibrate—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000453	0.00142	CcSEcCtD
Bezafibrate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000452	0.00142	CcSEcCtD
Bezafibrate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000451	0.00142	CcSEcCtD
Bezafibrate—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000448	0.00141	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.0014	CcSEcCtD
Bezafibrate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000446	0.0014	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.0014	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.0014	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.00137	CcSEcCtD
Bezafibrate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000435	0.00137	CcSEcCtD
Bezafibrate—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000434	0.0117	CbGpPWpGaD
Bezafibrate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.00136	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00135	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.00132	CcSEcCtD
Bezafibrate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.00132	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000417	0.0113	CbGpPWpGaD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00131	CcSEcCtD
Bezafibrate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000416	0.00131	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.0013	CcSEcCtD
Bezafibrate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000409	0.00128	CcSEcCtD
Bezafibrate—Pain—Etoposide—peripheral nervous system neoplasm	0.000409	0.00128	CcSEcCtD
Bezafibrate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00127	CcSEcCtD
Bezafibrate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000404	0.00127	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.00125	CcSEcCtD
Bezafibrate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000392	0.00123	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000391	0.00123	CcSEcCtD
Bezafibrate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00039	0.00123	CcSEcCtD
Bezafibrate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000386	0.00121	CcSEcCtD
Bezafibrate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000386	0.00121	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.00121	CcSEcCtD
Bezafibrate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000384	0.00121	CcSEcCtD
Bezafibrate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.00121	CcSEcCtD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00038	0.0103	CbGpPWpGaD
Bezafibrate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00038	0.00119	CcSEcCtD
Bezafibrate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000378	0.00119	CcSEcCtD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—MYC—peripheral nervous system neoplasm	0.000377	0.0102	CbGpPWpGaD
Bezafibrate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000374	0.00118	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000373	0.0101	CbGpPWpGaD
Bezafibrate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000373	0.00117	CcSEcCtD
Bezafibrate—Rash—Vincristine—peripheral nervous system neoplasm	0.000372	0.00117	CcSEcCtD
Bezafibrate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000372	0.00117	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00116	CcSEcCtD
Bezafibrate—Headache—Vincristine—peripheral nervous system neoplasm	0.00037	0.00116	CcSEcCtD
Bezafibrate—PPARD—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000367	0.00991	CbGpPWpGaD
Bezafibrate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000364	0.00114	CcSEcCtD
Bezafibrate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000357	0.00112	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000357	0.00112	CcSEcCtD
Bezafibrate—PPARA—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000356	0.00962	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000352	0.00111	CcSEcCtD
Bezafibrate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000351	0.0011	CcSEcCtD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000348	0.0094	CbGpPWpGaD
Bezafibrate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.00109	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.00108	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00108	CcSEcCtD
Bezafibrate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000338	0.00106	CcSEcCtD
Bezafibrate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00105	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00104	CcSEcCtD
Bezafibrate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000329	0.00103	CcSEcCtD
Bezafibrate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000329	0.00103	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00103	CcSEcCtD
Bezafibrate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000327	0.00103	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00102	CcSEcCtD
Bezafibrate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000316	0.000994	CcSEcCtD
Bezafibrate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000992	CcSEcCtD
Bezafibrate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00031	0.000974	CcSEcCtD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000309	0.00834	CbGpPWpGaD
Bezafibrate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000969	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000955	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000954	CcSEcCtD
Bezafibrate—Rash—Etoposide—peripheral nervous system neoplasm	0.000301	0.000947	CcSEcCtD
Bezafibrate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000301	0.000947	CcSEcCtD
Bezafibrate—PPARD—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000301	0.00813	CbGpPWpGaD
Bezafibrate—Headache—Etoposide—peripheral nervous system neoplasm	0.0003	0.000941	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000941	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	0.000298	0.00805	CbGpPWpGaD
Bezafibrate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000918	CcSEcCtD
Bezafibrate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000284	0.000893	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000883	CcSEcCtD
Bezafibrate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00028	0.00756	CbGpPWpGaD
Bezafibrate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000879	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000278	0.00752	CbGpPWpGaD
Bezafibrate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000837	CcSEcCtD
Bezafibrate—HMGCR—TOR Signaling—AKT1—peripheral nervous system neoplasm	0.000265	0.00717	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000825	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—EED—peripheral nervous system neoplasm	0.000261	0.00706	CbGpPWpGaD
Bezafibrate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000813	CcSEcCtD
Bezafibrate—PPARG—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000255	0.0069	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000251	0.00677	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000249	0.00673	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000247	0.00669	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000247	0.00667	CbGpPWpGaD
Bezafibrate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000774	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000767	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000763	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000762	CcSEcCtD
Bezafibrate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000741	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00072	CcSEcCtD
Bezafibrate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00072	CcSEcCtD
Bezafibrate—PPARA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000229	0.00619	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	0.000228	0.00616	CbGpPWpGaD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00071	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000705	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000221	0.00596	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000689	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000686	CcSEcCtD
Bezafibrate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000669	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000666	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000666	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000666	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000209	0.00565	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000203	0.00549	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000637	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—peripheral nervous system neoplasm	0.0002	0.00539	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000199	0.00539	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—EED—peripheral nervous system neoplasm	0.000199	0.00538	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000621	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000619	CcSEcCtD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000196	0.0053	CbGpPWpGaD
Bezafibrate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000616	CcSEcCtD
Bezafibrate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000596	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—MYC—peripheral nervous system neoplasm	0.000187	0.00505	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—TP53—peripheral nervous system neoplasm	0.000187	0.00504	CbGpPWpGaD
Bezafibrate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000576	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000574	CcSEcCtD
Bezafibrate—Aminohippurate—ABCB1—peripheral nervous system neoplasm	0.00018	0.364	CrCbGaD
Bezafibrate—PPARG—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000177	0.00479	CbGpPWpGaD
Bezafibrate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000557	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000551	CcSEcCtD
Bezafibrate—PPARA—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000174	0.0047	CbGpPWpGaD
Bezafibrate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000533	CcSEcCtD
Bezafibrate—HMGCR—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000169	0.00457	CbGpPWpGaD
Bezafibrate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000531	CcSEcCtD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000169	0.00456	CbGpPWpGaD
Bezafibrate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000531	CcSEcCtD
Bezafibrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000169	0.00456	CbGpPWpGaD
Bezafibrate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000528	CcSEcCtD
Bezafibrate—Indomethacin—ABCB1—peripheral nervous system neoplasm	0.000165	0.334	CrCbGaD
Bezafibrate—PPARG—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000164	0.00444	CbGpPWpGaD
Bezafibrate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000515	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—peripheral nervous system neoplasm	0.000164	0.00443	CbGpPWpGaD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000161	0.00434	CbGpPWpGaD
Bezafibrate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000159	0.0005	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000159	0.0043	CbGpPWpGaD
Bezafibrate—HMGCR—SREBP signalling—AKT1—peripheral nervous system neoplasm	0.000158	0.00426	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—AKT1—peripheral nervous system neoplasm	0.000158	0.00426	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000157	0.00423	CbGpPWpGaD
Bezafibrate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000491	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000491	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000156	0.0042	CbGpPWpGaD
Bezafibrate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000488	CcSEcCtD
Bezafibrate—PPARA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000155	0.00418	CbGpPWpGaD
Bezafibrate—Glyburide—ABCB1—peripheral nervous system neoplasm	0.000149	0.302	CrCbGaD
Bezafibrate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000463	CcSEcCtD
Bezafibrate—PPARD—Metabolism—GNS—peripheral nervous system neoplasm	0.000147	0.00397	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—EED—peripheral nervous system neoplasm	0.000143	0.00386	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—NME1—peripheral nervous system neoplasm	0.000141	0.00381	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000141	0.0038	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—COX2—peripheral nervous system neoplasm	0.000136	0.00366	CbGpPWpGaD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00013	0.0035	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—AKT1—peripheral nervous system neoplasm	0.00013	0.0035	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000129	0.0035	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000129	0.00348	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000125	0.00337	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000124	0.00336	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000123	0.00332	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GNS—peripheral nervous system neoplasm	0.000122	0.00331	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000121	0.00328	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—NME1—peripheral nervous system neoplasm	0.000117	0.00317	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000117	0.00315	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000114	0.00308	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—COX2—peripheral nervous system neoplasm	0.000113	0.00305	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000113	0.00305	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GNS—peripheral nervous system neoplasm	0.000112	0.00303	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000111	0.003	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000109	0.00295	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—NME1—peripheral nervous system neoplasm	0.000107	0.0029	CbGpPWpGaD
Bezafibrate—PPARG—SREBP signalling—AKT1—peripheral nervous system neoplasm	0.000103	0.00279	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—COX2—peripheral nervous system neoplasm	0.000103	0.00279	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000102	0.00275	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	9.97e-05	0.0027	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.39e-05	0.00254	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.22e-05	0.00249	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.21e-05	0.00249	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ENO2—peripheral nervous system neoplasm	8.9e-05	0.00241	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.74e-05	0.00236	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.42e-05	0.00228	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MET—peripheral nervous system neoplasm	8.31e-05	0.00225	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.11e-05	0.00219	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GNS—peripheral nervous system neoplasm	8.02e-05	0.00217	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	7.99e-05	0.00216	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—NME1—peripheral nervous system neoplasm	7.69e-05	0.00208	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—PTPN11—peripheral nervous system neoplasm	7.68e-05	0.00208	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—BCHE—peripheral nervous system neoplasm	7.52e-05	0.00203	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.43e-05	0.00201	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ENO2—peripheral nervous system neoplasm	7.41e-05	0.002	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—COX2—peripheral nervous system neoplasm	7.4e-05	0.002	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.26e-05	0.00196	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.26e-05	0.00196	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.17e-05	0.00194	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—TH—peripheral nervous system neoplasm	7.07e-05	0.00191	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ENO2—peripheral nervous system neoplasm	6.78e-05	0.00183	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.58e-05	0.00178	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	6.32e-05	0.00171	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—BCHE—peripheral nervous system neoplasm	6.26e-05	0.00169	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.07e-05	0.00164	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	6.05e-05	0.00164	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	6e-05	0.00162	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.98e-05	0.00162	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MET—peripheral nervous system neoplasm	5.95e-05	0.00161	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—TH—peripheral nervous system neoplasm	5.89e-05	0.00159	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	5.83e-05	0.00158	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GNAS—peripheral nervous system neoplasm	5.77e-05	0.00156	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—BCHE—peripheral nervous system neoplasm	5.73e-05	0.00155	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ABCB1—peripheral nervous system neoplasm	5.66e-05	0.00153	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	5.51e-05	0.00149	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.47e-05	0.00148	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.47e-05	0.00148	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TH—peripheral nervous system neoplasm	5.39e-05	0.00146	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.3e-05	0.00143	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.2e-05	0.00141	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.2e-05	0.00141	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.02e-05	0.00136	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	4.86e-05	0.00131	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GNAS—peripheral nervous system neoplasm	4.81e-05	0.0013	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ABCB1—peripheral nervous system neoplasm	4.72e-05	0.00128	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.62e-05	0.00125	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.57e-05	0.00124	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.55e-05	0.00123	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GNAS—peripheral nervous system neoplasm	4.4e-05	0.00119	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	4.35e-05	0.00118	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ABCB1—peripheral nervous system neoplasm	4.31e-05	0.00117	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.17e-05	0.00113	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	4.11e-05	0.00111	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.99e-05	0.00108	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	3.96e-05	0.00107	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.92e-05	0.00106	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TH—peripheral nervous system neoplasm	3.86e-05	0.00104	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.83e-05	0.00103	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	3.79e-05	0.00103	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	3.65e-05	0.000987	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	3.63e-05	0.000981	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	3.48e-05	0.00094	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.38e-05	0.000914	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	3.35e-05	0.000905	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	3.31e-05	0.000895	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	3.28e-05	0.000886	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	3.23e-05	0.000874	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	3.15e-05	0.000852	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	3.09e-05	0.000836	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.08e-05	0.000834	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	3.04e-05	0.000822	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.98e-05	0.000807	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—peripheral nervous system neoplasm	2.89e-05	0.000781	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.69e-05	0.000728	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.48e-05	0.000671	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.43e-05	0.000658	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.42e-05	0.000655	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.4e-05	0.000648	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—peripheral nervous system neoplasm	2.2e-05	0.000595	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	2.2e-05	0.000594	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.14e-05	0.000578	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.03e-05	0.000548	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—peripheral nervous system neoplasm	2e-05	0.000542	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.95e-05	0.000527	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.93e-05	0.000523	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	1.91e-05	0.000515	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.87e-05	0.000505	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.86e-05	0.000502	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.8e-05	0.000486	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.000479	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.75e-05	0.000472	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	1.58e-05	0.000426	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-05	0.000421	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.56e-05	0.00042	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—peripheral nervous system neoplasm	1.53e-05	0.000413	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.53e-05	0.000413	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000385	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.000378	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—peripheral nervous system neoplasm	1.3e-05	0.000351	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000321	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.18e-05	0.000319	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000296	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.97e-06	0.00027	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.51e-06	0.000257	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	9.38e-06	0.000253	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	8.51e-06	0.00023	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.65e-06	0.000207	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.51e-06	0.000203	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	6.7e-06	0.000181	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.2e-06	0.000113	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	3.85e-06	0.000104	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.07e-06	5.58e-05	CbGpPWpGaD
